These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 19960022

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M.
    Biochem Biophys Res Commun; 2008 Dec 05; 377(1):114-9. PubMed ID: 18834855
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT, Goan YG, Lu PJ.
    Oncogene; 2009 Sep 24; 28(38):3360-70. PubMed ID: 19597470
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S, Sun L, Huang F.
    Arch Med Res; 2010 Feb 24; 41(2):67-74. PubMed ID: 20470934
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
    Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, Jackson AL, Carleton MO, Linsley PS, Cleary MA, Chau BN.
    Cancer Res; 2008 Dec 15; 68(24):10105-12. PubMed ID: 19074876
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
    Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, Dahiya R.
    Oncogene; 2009 Apr 09; 28(14):1714-24. PubMed ID: 19252524
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. c-Myc-regulated microRNAs modulate E2F1 expression.
    O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT.
    Nature; 2005 Jun 09; 435(7043):839-43. PubMed ID: 15944709
    [Abstract] [Full Text] [Related]

  • 17. The miR-34 family in cancer and apoptosis.
    Hermeking H.
    Cell Death Differ; 2010 Feb 09; 17(2):193-9. PubMed ID: 19461653
    [Abstract] [Full Text] [Related]

  • 18. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC.
    Mol Cancer; 2007 Sep 25; 6():60. PubMed ID: 17894887
    [Abstract] [Full Text] [Related]

  • 19. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts.
    Maes OC, Sarojini H, Wang E.
    J Cell Physiol; 2009 Oct 25; 221(1):109-19. PubMed ID: 19475566
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
    Ichimura A, Ruike Y, Terasawa K, Shimizu K, Tsujimoto G.
    Mol Pharmacol; 2010 Jun 25; 77(6):1016-24. PubMed ID: 20299489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.